€22.18
0.18% today
Amsterdam, Jan 30, 05:35 pm CET
ISIN
BE0003818359
Symbol
GLPG
Sector
Industry

Galapagos Stock price

€22.18
-4.12 15.67% 1M
-3.30 12.95% 6M
-4.34 16.37% YTD
-12.83 36.65% 1Y
-37.40 62.77% 3Y
-183.62 89.22% 5Y
+4.00 22.00% 10Y
Amsterdam, Closing price Thu, Jan 30 2025
-0.04 0.18%
ISIN
BE0003818359
Symbol
GLPG
Sector
Industry

Key metrics

Market capitalization €1.46b
Enterprise Value €-1.90b
P/E (TTM) P/E ratio negative
P/B ratio (TTM) P/B ratio 0.51
Cash position €3.38b
P/E forward negative
P/S forward 5.18
EV/Sales forward negative

Is Galapagos a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,875 stocks worldwide.

Galapagos Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a Galapagos forecast:

2x Buy
15%
9x Hold
69%
2x Sell
15%

Analyst Opinions

13 Analysts have issued a Galapagos forecast:

Buy
15%
Hold
69%
Sell
15%

Financial data from Galapagos

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
60 60
50% 50%
100%
- Direct Costs 0.02 0.02
100% 100%
0%
60 60
48% 48%
100%
- Selling and Administrative Expenses 29 29
52% 52%
49%
- Research and Development Expense 93 93
7% 7%
155%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT -62 -62
34% 34%
-104%
Net Profit -50 -50
295% 295%
-84%

In millions EUR.

Don't miss a Thing! We will send you all news about Galapagos directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Galapagos Stock News

Positive
Forbes
9 days ago
Deal Overview
Neutral
GlobeNewsWire
23 days ago
Galapagos intends to create a new company with approximately €2.45 billion in cash dedicated to building a pipeline of innovative medicines through transformational transactions
Neutral
GlobeNewsWire
23 days ago
Mechelen, Belgium; January 7, 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that the Company will present at the 43 rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025, at 1:30 pm PT in San Francisco. A live webcast of the presentation will be accessible on the Investors page of the Company's website at www.glpg.com/investors. A replay of the web...
More Galapagos News

Company Profile

Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. It operates through the Research & Development and Fee-for-Services segment. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.

Head office Belgium
CEO Paulus Stoffels
Employees 1,123
Founded 1999
Website www.glpg.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today